← Scroll for more →
Amylyx Pharmaceuticals, Inc. (AMLX)
Pharmaceutical Preparations
Latest Price
$28.68
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
2.15
P/B Ratio
13.33
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 16.73M | $300.0M | 15.02% | +97.4K | 2026-06-30 |
| BlackRock, Inc. | 8.83M | $158.0M | 7.93% | -1.8K | 2026-06-30 |
| Perceptive Advisors LLC | 8.33M | $149.0M | 7.48% | +50.0K | 2026-06-30 |
| TCG Crossover Management, LLC | 6.24M | $112.0M | 5.61% | -- | 2026-06-30 |
| Commodore Capital LP | 5.65M | $101.0M | 5.07% | -- | 2026-06-30 |
| Jupiter Topco LLC | 5.24M | $94.0M | 4.70% | -- | 2026-06-30 |
| Saturn V Capital Management LP | 4.62M | $83.0M | 4.15% | +274.2K | 2026-06-30 |
| Vanguard Capital Management LLC | 4.22M | $75.0M | 3.79% | +82.6K | 2026-06-30 |
| Morgan Stanley | 3.13M | $56.0M | 2.81% | +955.3K | 2026-06-30 |
| Driehaus Capital Management LLC | 3.04M | $54.0M | 2.73% | +49.8K | 2026-06-30 |